-
1
-
-
0023423794
-
Virus interference: I. The interferon. by A. Isaacs and J. Lindenmann, 1957
-
A. Isaacs, and J. Lindenmann Virus interference: I. The interferon. By A. Isaacs and J. Lindenmann, 1957 J Interf Res 7 1987 429 438
-
(1987)
J Interf Res
, vol.7
, pp. 429-438
-
-
Isaacs, A.1
Lindenmann, J.2
-
2
-
-
17544395282
-
The PKR protein kinase-an interferon-inducible regulator of cell growth and differentiation
-
C.E. Samuel, K.L. Kuhen, C.X. George, L.G. Ortega, R. Rende-Fournier, and H. Tanaka The PKR protein kinase-an interferon-inducible regulator of cell growth and differentiation Int J Hematol 65 1997 227 237
-
(1997)
Int J Hematol
, vol.65
, pp. 227-237
-
-
Samuel, C.E.1
Kuhen, K.L.2
George, C.X.3
Ortega, L.G.4
Rende-Fournier, R.5
Tanaka, H.6
-
3
-
-
0031008870
-
Interferon regulatory factors: Growth control and histone gene regulation-it's not just interferon anymore
-
P.S. Vaughan, A.J. van Wijnen, J.L. Stein, and G.S. Stein Interferon regulatory factors: growth control and histone gene regulation-it's not just interferon anymore J Mol Med 75 1997 348 359
-
(1997)
J Mol Med
, vol.75
, pp. 348-359
-
-
Vaughan, P.S.1
Van Wijnen, A.J.2
Stein, J.L.3
Stein, G.S.4
-
4
-
-
0342656166
-
The immune system-first of two parts
-
P.J. Delves, and I.M. Roitt The immune system-first of two parts N Engl J Med 343 2000 37 49
-
(2000)
N Engl J Med
, vol.343
, pp. 37-49
-
-
Delves, P.J.1
Roitt, I.M.2
-
5
-
-
0032547938
-
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
-
J.G. McHutchison, S.C. Gordon, E.R. Schiff, M.L. Shiffman, W.M. Lee, and V.K. Rustgi Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C N Engl J Med 339 1998 1485 1492
-
(1998)
N Engl J Med
, vol.339
, pp. 1485-1492
-
-
McHutchison, J.G.1
Gordon, S.C.2
Schiff, E.R.3
Shiffman, M.L.4
Lee, W.M.5
Rustgi, V.K.6
-
7
-
-
0034727059
-
Intramuscular interferon beta-1A therapy initiated during a first demyelinating event in multiple sclerosis
-
L.D. Jacobs, R.W. Beck, J.H. Simon, R.P. Kinkel, C.M. Brownscheidle, and T.J. Murray Intramuscular interferon beta-1A therapy initiated during a first demyelinating event in multiple sclerosis N Engl J Med 343 2000 898 904
-
(2000)
N Engl J Med
, vol.343
, pp. 898-904
-
-
Jacobs, L.D.1
Beck, R.W.2
Simon, J.H.3
Kinkel, R.P.4
Brownscheidle, C.M.5
Murray, T.J.6
-
8
-
-
2542599149
-
Coxsackieviral replication and pathogenicity: Lessons from gene modified animal models
-
R. Wessely Coxsackieviral replication and pathogenicity: lessons from gene modified animal models Med Microbiol Immunol 193 2004 71 74
-
(2004)
Med Microbiol Immunol
, vol.193
, pp. 71-74
-
-
Wessely, R.1
-
9
-
-
0035814783
-
Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: Implications for mortality and early viral replication
-
R. Wessely, K. Klingel, K.U. Knowlton, and R. Kandolf Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replication Circulation 103 2001 756 761
-
(2001)
Circulation
, vol.103
, pp. 756-761
-
-
Wessely, R.1
Klingel, K.2
Knowlton, K.U.3
Kandolf, R.4
-
10
-
-
0038120010
-
Interferon-{beta} treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction
-
U. Kuhl, M. Pauschinger, P.L. Schwimmbeck, B. Seeberg, C. Lober, and M. Noutsias Interferon-{beta} treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction Circulation 107 2003 2793 2798
-
(2003)
Circulation
, vol.107
, pp. 2793-2798
-
-
Kuhl, U.1
Pauschinger, M.2
Schwimmbeck, P.L.3
Seeberg, B.4
Lober, C.5
Noutsias, M.6
-
11
-
-
0035873882
-
Cell cycle in vasculoproliferative diseases: Potential interventions and routes of delivery
-
V. Sriram, and C. Patterson Cell cycle in vasculoproliferative diseases: potential interventions and routes of delivery Circulation 103 2001 2414 2419
-
(2001)
Circulation
, vol.103
, pp. 2414-2419
-
-
Sriram, V.1
Patterson, C.2
-
12
-
-
0036851826
-
Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies
-
V.J. Dzau, R.C. Braun-Dullaeus, and D.G. Sedding Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies Nat Med 8 2002 1249 1256
-
(2002)
Nat Med
, vol.8
, pp. 1249-1256
-
-
Dzau, V.J.1
Braun-Dullaeus, R.C.2
Sedding, D.G.3
-
13
-
-
2942612344
-
Control of vascular cell proliferation and migration by cyclin-dependent kinase signalling: New perspectives and therapeutic potential
-
V. Andres Control of vascular cell proliferation and migration by cyclin-dependent kinase signalling: new perspectives and therapeutic potential Cardiovasc Res 63 2004 11 21
-
(2004)
Cardiovasc Res
, vol.63
, pp. 11-21
-
-
Andres, V.1
-
14
-
-
0032493266
-
Cell cycle progression: New therapeutic target for vascular proliferative disease
-
R.C. Braun-Dullaeus, M.J. Mann, and V.J. Dzau Cell cycle progression: new therapeutic target for vascular proliferative disease Circulation 98 1998 82 89
-
(1998)
Circulation
, vol.98
, pp. 82-89
-
-
Braun-Dullaeus, R.C.1
Mann, M.J.2
Dzau, V.J.3
-
15
-
-
0036690536
-
IFN-alpha/beta receptor interactions to biologic outcomes: Understanding the circuitry
-
M.M. Brierley, and E.N. Fish IFN-alpha/beta receptor interactions to biologic outcomes: understanding the circuitry J Interferon Cytokine Res 22 2002 835 845
-
(2002)
J Interferon Cytokine Res
, vol.22
, pp. 835-845
-
-
Brierley, M.M.1
Fish, E.N.2
-
16
-
-
0031657551
-
How cells respond to interferons
-
G.R. Stark, I.M. Kerr, B.R.G. Williams, R.H. Silverman, and R.D. Schreiber How cells respond to interferons Ann Rev Biochem 67 1998 227 264
-
(1998)
Ann Rev Biochem
, vol.67
, pp. 227-264
-
-
Stark, G.R.1
Kerr, I.M.2
Williams, B.R.G.3
Silverman, R.H.4
Schreiber, R.D.5
-
17
-
-
0037082487
-
Sequential production of interferon-gamma by NK1.1+T cells and natural killer cells is essential for the antimetastatic effect of alpha- galactosylceramide
-
M.J. Smyth, N.Y. Crowe, D.G. Pellicci, K. Kyparissoudis, J.M. Kelly, and K. Takeda Sequential production of interferon-gamma by NK1.1+T cells and natural killer cells is essential for the antimetastatic effect of alpha- galactosylceramide Blood 99 2002 1259 1266
-
(2002)
Blood
, vol.99
, pp. 1259-1266
-
-
Smyth, M.J.1
Crowe, N.Y.2
Pellicci, D.G.3
Kyparissoudis, K.4
Kelly, J.M.5
Takeda, K.6
-
18
-
-
0030889207
-
The IFN gamma receptor: A paradigm for cytokine receptor signaling
-
E.A. Bach, M. Aguet, and R.D. Schreiber The IFN gamma receptor: a paradigm for cytokine receptor signaling Annu Rev Immunol 15 1997 563 591
-
(1997)
Annu Rev Immunol
, vol.15
, pp. 563-591
-
-
Bach, E.A.1
Aguet, M.2
Schreiber, R.D.3
-
19
-
-
0027411525
-
The molecular cell biology of interferon-gamma and its receptor
-
M.A. Farrar, and R.D. Schreiber The molecular cell biology of interferon-gamma and its receptor Annu Rev Immunol 11 1993 571 611
-
(1993)
Annu Rev Immunol
, vol.11
, pp. 571-611
-
-
Farrar, M.A.1
Schreiber, R.D.2
-
20
-
-
0742322159
-
Interferons: Mechanisms of action and clinical applications
-
S. Parmar, and L.C. Platanias Interferons: mechanisms of action and clinical applications Curr Opin Oncol 15 2003 431 439
-
(2003)
Curr Opin Oncol
, vol.15
, pp. 431-439
-
-
Parmar, S.1
Platanias, L.C.2
-
21
-
-
0028299340
-
The human interferon alpha/beta receptor: Characterization and molecular cloning
-
D. Novick, B. Cohen, and M. Rubinstein The human interferon alpha/beta receptor: characterization and molecular cloning Cell 77 1994 391 400
-
(1994)
Cell
, vol.77
, pp. 391-400
-
-
Novick, D.1
Cohen, B.2
Rubinstein, M.3
-
22
-
-
0032417696
-
Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays
-
S.D. Der, A. Zhou, B.R. Williams, and R.H. Silverman Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays Proc Natl Acad Sci U S A 95 1998 15623 15628
-
(1998)
Proc Natl Acad Sci U S a
, vol.95
, pp. 15623-15628
-
-
Der, S.D.1
Zhou, A.2
Williams, B.R.3
Silverman, R.H.4
-
23
-
-
0033230617
-
PKR; A sentinel kinase for cellular stress
-
B.R. Williams PKR; a sentinel kinase for cellular stress Oncogene 18 1999 6112 6120
-
(1999)
Oncogene
, vol.18
, pp. 6112-6120
-
-
Williams, B.R.1
-
24
-
-
0033909789
-
Novel functions of interferon-induced proteins
-
G.C. Sen Novel functions of interferon-induced proteins Sem Cancer Biol 10 2000 93 101
-
(2000)
Sem Cancer Biol
, vol.10
, pp. 93-101
-
-
Sen, G.C.1
-
25
-
-
0034769960
-
Viruses and interferons
-
G.C. Sen Viruses and interferons Annu Rev Microbiol 55 2001 255 281
-
(2001)
Annu Rev Microbiol
, vol.55
, pp. 255-281
-
-
Sen, G.C.1
-
26
-
-
0037154838
-
Role of nucleoporin induction in releasing an mRNA nuclear export block
-
J. Enninga, D.E. Levy, G. Blobel, and B.M. Fontoura Role of nucleoporin induction in releasing an mRNA nuclear export block Science 295 2002 1523 1525
-
(2002)
Science
, vol.295
, pp. 1523-1525
-
-
Enninga, J.1
Levy, D.E.2
Blobel, G.3
Fontoura, B.M.4
-
27
-
-
2642685827
-
A single DNA response element can confer inducibility by both alpha- and gamma-interferons
-
L.E. Reid, A.H. Brasnett, C.S. Gilbert, A.C. Porter, D.R. Gewert, and G.R. Stark A single DNA response element can confer inducibility by both alpha- and gamma-interferons Proc Natl Acad Sci U S A 86 1989 840 844
-
(1989)
Proc Natl Acad Sci U S a
, vol.86
, pp. 840-844
-
-
Reid, L.E.1
Brasnett, A.H.2
Gilbert, C.S.3
Porter, A.C.4
Gewert, D.R.5
Stark, G.R.6
-
28
-
-
0022919476
-
Interferon-stimulated transcription: Isolation of an inducible gene and identification of its regulatory region
-
D. Levy, A. Larner, A. Chaudhuri, L.E. Babiss, and J.E. Darnell Jr. Interferon-stimulated transcription: isolation of an inducible gene and identification of its regulatory region Proc Natl Acad Sci U S A 83 1986 8929 8933
-
(1986)
Proc Natl Acad Sci U S a
, vol.83
, pp. 8929-8933
-
-
Levy, D.1
Larner, A.2
Chaudhuri, A.3
Babiss, L.E.4
Darnell Jr., J.E.5
-
29
-
-
0141561934
-
Alternate interferon signaling pathways
-
D.V. Kalvakolanu Alternate interferon signaling pathways Pharmacol Ther 100 2003 1 29
-
(2003)
Pharmacol Ther
, vol.100
, pp. 1-29
-
-
Kalvakolanu, D.V.1
-
30
-
-
0026019924
-
Cytoplasmic activation of GAF, an IFN-gamma-regulated DNA-binding factor
-
T. Decker, D.J. Lew, J. Mirkovitch, and J.E. Darnell Jr Cytoplasmic activation of GAF, an IFN-gamma-regulated DNA-binding factor EMBO J 10 1991 927 932
-
(1991)
EMBO J
, vol.10
, pp. 927-932
-
-
Decker, T.1
Lew, D.J.2
Mirkovitch, J.3
Darnell Jr., J.E.4
-
31
-
-
0028234529
-
Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins
-
J.E. Darnell Jr., I.M. Kerr, and G.R. Stark Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins Science 264 1994 1415 1421
-
(1994)
Science
, vol.264
, pp. 1415-1421
-
-
Darnell Jr., J.E.1
Kerr, I.M.2
Stark, G.R.3
-
32
-
-
0027159217
-
The genomic structure of the murine ICSBP gene reveals the presence of the gamma interferon-responsive element, to which an ISGF3 alpha subunit (or similar) molecule binds
-
Y. Kanno, C.A. Kozak, C. Schindler, P.H. Driggers, D.L. Ennist, and S.L. Gleason The genomic structure of the murine ICSBP gene reveals the presence of the gamma interferon-responsive element, to which an ISGF3 alpha subunit (or similar) molecule binds Mol Cell Biol 13 1993 3951 3963
-
(1993)
Mol Cell Biol
, vol.13
, pp. 3951-3963
-
-
Kanno, Y.1
Kozak, C.A.2
Schindler, C.3
Driggers, P.H.4
Ennist, D.L.5
Gleason, S.L.6
-
33
-
-
0025086043
-
Transcription factors induced by interferons alpha and gamma
-
A.M. Imam, A.M. Ackrill, T.C. Dale, I.M. Kerr, and G.R. Stark Transcription factors induced by interferons alpha and gamma Nucleic Acids Res 18 1990 6573 6580
-
(1990)
Nucleic Acids Res
, vol.18
, pp. 6573-6580
-
-
Imam, A.M.1
Ackrill, A.M.2
Dale, T.C.3
Kerr, I.M.4
Stark, G.R.5
-
34
-
-
0025284811
-
Purification and cloning of interferon-stimulated gene factor 2 (ISGF2): ISGF2 (IRF-1) can bind to the promoters of both beta interferon- and interferon-stimulated genes but is not a primary transcriptional activator of either
-
R. Pine, T. Decker, D.S. Kessler, D.E. Levy, and J.E. Darnell Jr. Purification and cloning of interferon-stimulated gene factor 2 (ISGF2): ISGF2 (IRF-1) can bind to the promoters of both beta interferon- and interferon-stimulated genes but is not a primary transcriptional activator of either Mol Cell Biol 10 1990 2448 2457
-
(1990)
Mol Cell Biol
, vol.10
, pp. 2448-2457
-
-
Pine, R.1
Decker, T.2
Kessler, D.S.3
Levy, D.E.4
Darnell Jr., J.E.5
-
35
-
-
0032841028
-
Interferon regulatory factors: The next generation
-
Y. Mamane, C. Heylbroeck, P. Genin, M. Algarte, M.J. Servant, and C. Lepage Interferon regulatory factors: the next generation Gene 237 1999 1 14
-
(1999)
Gene
, vol.237
, pp. 1-14
-
-
Mamane, Y.1
Heylbroeck, C.2
Genin, P.3
Algarte, M.4
Servant, M.J.5
Lepage, C.6
-
37
-
-
0036182472
-
IRF-1 as a negative regulator of cell proliferation
-
G. Romeo, G. Fiorucci, M.V. Chiantore, Z.A. Percario, S. Vannucchi, and E. Affabris IRF-1 as a negative regulator of cell proliferation J Interferon Cytokine Res 22 2002 39 47
-
(2002)
J Interferon Cytokine Res
, vol.22
, pp. 39-47
-
-
Romeo, G.1
Fiorucci, G.2
Chiantore, M.V.3
Percario, Z.A.4
Vannucchi, S.5
Affabris, E.6
-
38
-
-
0030665032
-
KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway
-
S.J. Gao, C. Boshoff, S. Jayachandra, R.A. Weiss, Y. Chang, and P.S. Moore KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway Oncogene 15 1997 1979 1985
-
(1997)
Oncogene
, vol.15
, pp. 1979-1985
-
-
Gao, S.J.1
Boshoff, C.2
Jayachandra, S.3
Weiss, R.A.4
Chang, Y.5
Moore, P.S.6
-
39
-
-
0035864786
-
HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway
-
R. Lin, P. Genin, Y. Mamane, M. Sgarbanti, A. Battistini, and W.J. Harrington Jr. HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway Oncogene 20 2001 800 811
-
(2001)
Oncogene
, vol.20
, pp. 800-811
-
-
Lin, R.1
Genin, P.2
Mamane, Y.3
Sgarbanti, M.4
Battistini, A.5
Harrington Jr., W.J.6
-
40
-
-
0033569766
-
Activation of the p38 mitogen-activated protein kinase by type I interferons
-
S. Uddin, B. Majchrzak, J. Woodson, P. Arunkumar, Y. Alsayed, and R. Pine Activation of the p38 mitogen-activated protein kinase by type I interferons J Biol Chem 274 1999 30127 30131
-
(1999)
J Biol Chem
, vol.274
, pp. 30127-30131
-
-
Uddin, S.1
Majchrzak, B.2
Woodson, J.3
Arunkumar, P.4
Alsayed, Y.5
Pine, R.6
-
41
-
-
0029133702
-
Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins
-
M. David, E. Petricoin 3rd., C. Benjamin, R. Pine, M.J. Weber, and A.C. Larner Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins Science 269 1995 1721 1723
-
(1995)
Science
, vol.269
, pp. 1721-1723
-
-
David, M.1
Petricoin III, E.2
Benjamin, C.3
Pine, R.4
Weber, M.J.5
Larner, A.C.6
-
42
-
-
0037040869
-
Activation of the p38 mitogen-activated protein kinase mediates the suppressive effects of type I interferons and transforming growth factor-beta on normal hematopoiesis
-
A. Verma, D.K. Deb, A. Sassano, S. Uddin, J. Varga, and A. Wickrema Activation of the p38 mitogen-activated protein kinase mediates the suppressive effects of type I interferons and transforming growth factor-beta on normal hematopoiesis J Biol Chem 277 2002 7726 7735
-
(2002)
J Biol Chem
, vol.277
, pp. 7726-7735
-
-
Verma, A.1
Deb, D.K.2
Sassano, A.3
Uddin, S.4
Varga, J.5
Wickrema, A.6
-
43
-
-
0034660892
-
The Pezcoller lecture: Cancer cell cycles revisited
-
C.J. Sherr The Pezcoller lecture: cancer cell cycles revisited Cancer Res 60 2000 3689 3695
-
(2000)
Cancer Res
, vol.60
, pp. 3689-3695
-
-
Sherr, C.J.1
-
44
-
-
0033564697
-
CDK inhibitors: Positive and negative regulators of G1-phase progression
-
C.J. Sherr, and J.M. Roberts CDK inhibitors: positive and negative regulators of G1-phase progression Genes Dev 13 1999 1501 1512
-
(1999)
Genes Dev
, vol.13
, pp. 1501-1512
-
-
Sherr, C.J.1
Roberts, J.M.2
-
45
-
-
0033529122
-
Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins
-
O. Sangfelt, S. Erickson, J. Castro, T. Heiden, A. Gustafsson, and S. Einhorn Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins Oncogene 18 1999 2798 2810
-
(1999)
Oncogene
, vol.18
, pp. 2798-2810
-
-
Sangfelt, O.1
Erickson, S.2
Castro, J.3
Heiden, T.4
Gustafsson, A.5
Einhorn, S.6
-
46
-
-
19544389532
-
New pharmacokinetic and pharmacodynamic tools for interferon-alpha (IFN-alpha) treatment of human cancer
-
P. Tagliaferri, M. Caraglia, A. Budillon, M. Marra, G. Vitale, and C. Viscomi New pharmacokinetic and pharmacodynamic tools for interferon-alpha (IFN-alpha) treatment of human cancer Cancer Immunol Immunother 2004 Epub ahead of print
-
(2004)
Cancer Immunol Immunother
-
-
Tagliaferri, P.1
Caraglia, M.2
Budillon, A.3
Marra, M.4
Vitale, G.5
Viscomi, C.6
-
47
-
-
20844461132
-
Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: A randomized clinical trial
-
A. Keogh, M. Richardson, P. Ruygrok, P. Spratt, A. Galbraith, and G. O'Driscoll Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial Circulation 110 2004 2694 2700
-
(2004)
Circulation
, vol.110
, pp. 2694-2700
-
-
Keogh, A.1
Richardson, M.2
Ruygrok, P.3
Spratt, P.4
Galbraith, A.5
O'Driscoll, G.6
-
48
-
-
0038300674
-
Use of rapamycin slows progression of cardiac transplantation vasculopathy
-
D. Mancini, S. Pinney, D. Burkhoff, J. LaManca, S. Itescu, and E. Burke Use of rapamycin slows progression of cardiac transplantation vasculopathy Circulation 108 2003 48 53
-
(2003)
Circulation
, vol.108
, pp. 48-53
-
-
Mancini, D.1
Pinney, S.2
Burkhoff, D.3
Lamanca, J.4
Itescu, S.5
Burke, E.6
-
49
-
-
0035928843
-
Bench to bedside: The development of rapamycin and its application to stent restenosis
-
S.O. Marx, and A.R. Marks Bench to bedside: the development of rapamycin and its application to stent restenosis Circulation 104 2001 852 855
-
(2001)
Circulation
, vol.104
, pp. 852-855
-
-
Marx, S.O.1
Marks, A.R.2
-
50
-
-
0141765805
-
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery
-
J.W. Moses, M.B. Leon, J.J. Popma, P.J. Fitzgerald, D.R. Holmes, and C. O'Shaughnessy Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323
-
(2003)
N Engl J Med
, vol.349
, pp. 1315-1323
-
-
Moses, J.W.1
Leon, M.B.2
Popma, J.J.3
Fitzgerald, P.J.4
Holmes, D.R.5
O'Shaughnessy, C.6
-
51
-
-
0028933243
-
Binding of an interferon-inducible protein (p202) to the retinoblastoma protein
-
D. Choubey, and P. Lengyel Binding of an interferon-inducible protein (p202) to the retinoblastoma protein J Biol Chem 270 1995 6134 6140
-
(1995)
J Biol Chem
, vol.270
, pp. 6134-6140
-
-
Choubey, D.1
Lengyel, P.2
-
52
-
-
0029853903
-
Inhibition of E2F-mediated transcription by p202
-
D. Choubey, S.J. Li, B. Datta, J.U. Gutterman, and P. Lengyel Inhibition of E2F-mediated transcription by p202 EMBO J 15 1996 5668 5678
-
(1996)
EMBO J
, vol.15
, pp. 5668-5678
-
-
Choubey, D.1
Li, S.J.2
Datta, B.3
Gutterman, J.U.4
Lengyel, P.5
-
53
-
-
2342535203
-
C-Myc oncoprotein: Cell cycle-related events and new therapeutic challenges in cancer and cardiovascular diseases
-
F. de Nigris, V. Sica, J. Herrmann, G. Condorelli, A.R. Chade, and G. Tajana c-Myc oncoprotein: cell cycle-related events and new therapeutic challenges in cancer and cardiovascular diseases Cell Cycle 2 2003 325 328
-
(2003)
Cell Cycle
, vol.2
, pp. 325-328
-
-
De Nigris, F.1
Sica, V.2
Herrmann, J.3
Condorelli, G.4
Chade, A.R.5
Tajana, G.6
-
54
-
-
2342645571
-
The role of c-myc in regulation of translation initiation
-
E.V. Schmidt The role of c-myc in regulation of translation initiation Oncogene 23 2004 3217 3221
-
(2004)
Oncogene
, vol.23
, pp. 3217-3221
-
-
Schmidt, E.V.1
-
55
-
-
0021933901
-
Close link between reduction of c-myc expression by interferon and G0/G1 arrest
-
M. Einat, D. Resnitzky, and A. Kimchi Close link between reduction of c-myc expression by interferon and G0/G1 arrest Nature 313 1985 597 600
-
(1985)
Nature
, vol.313
, pp. 597-600
-
-
Einat, M.1
Resnitzky, D.2
Kimchi, A.3
-
56
-
-
0035120788
-
Engagement of the CrkL adaptor in interferon alpha signalling in BCR-ABL-expressing cells
-
I.M. Grumbach, I.A. Mayer, S. Uddin, F. Lekmine, B. Majchrzak, and H. Yamauchi Engagement of the CrkL adaptor in interferon alpha signalling in BCR-ABL-expressing cells Br J Haematol 112 2001 327 336
-
(2001)
Br J Haematol
, vol.112
, pp. 327-336
-
-
Grumbach, I.M.1
Mayer, I.A.2
Uddin, S.3
Lekmine, F.4
Majchrzak, B.5
Yamauchi, H.6
-
57
-
-
0029560027
-
Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element
-
M. Stadler, M.K. Chelbi-Alix, M.H. Koken, L. Venturini, C. Lee, and A. Saib Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element Oncogene 11 1995 2565 2573
-
(1995)
Oncogene
, vol.11
, pp. 2565-2573
-
-
Stadler, M.1
Chelbi-Alix, M.K.2
Koken, M.H.3
Venturini, L.4
Lee, C.5
Saib, A.6
-
58
-
-
0034688305
-
Cell growth regulatory and antiviral effects of the P69 isozyme of 2-5 (A) synthetase
-
A. Ghosh, S.N. Sarkar, and G.C. Sen Cell growth regulatory and antiviral effects of the P69 isozyme of 2-5 (A) synthetase Virology 266 2000 319 328
-
(2000)
Virology
, vol.266
, pp. 319-328
-
-
Ghosh, A.1
Sarkar, S.N.2
Sen, G.C.3
-
59
-
-
0018352913
-
Interferon-induced enzymatic activities and their role in the antiviral state
-
C. Baglioni Interferon-induced enzymatic activities and their role in the antiviral state Cell 17 1979 255 264
-
(1979)
Cell
, vol.17
, pp. 255-264
-
-
Baglioni, C.1
-
60
-
-
18544377048
-
Germline mutations in the ribonuclease L gene in families showing linkage with HPC1
-
J. Carpten, N. Nupponen, S. Isaacs, R. Sood, C. Robbins, and J. Xu Germline mutations in the ribonuclease L gene in families showing linkage with HPC1 Nat Genet 30 2002 181 184
-
(2002)
Nat Genet
, vol.30
, pp. 181-184
-
-
Carpten, J.1
Nupponen, N.2
Isaacs, S.3
Sood, R.4
Robbins, C.5
Xu, J.6
-
61
-
-
0036739922
-
Contribution of double-stranded RNA-activated protein kinase toward antiproliferative actions of heparin on vascular smooth muscle cells
-
R.C. Patel, I. Handy, and C.V. Patel Contribution of double-stranded RNA-activated protein kinase toward antiproliferative actions of heparin on vascular smooth muscle cells Arterioscler Thromb Vasc Biol 22 2002 1439 1444
-
(2002)
Arterioscler Thromb Vasc Biol
, vol.22
, pp. 1439-1444
-
-
Patel, R.C.1
Handy, I.2
Patel, C.V.3
-
62
-
-
0033972856
-
Apoptosis in inflammatory-fibroproliferative disorders of the vessel wall
-
K. Walsh, and J.M. Isner Apoptosis in inflammatory-fibroproliferative disorders of the vessel wall Cardiovasc Res 45 2000 756 765
-
(2000)
Cardiovasc Res
, vol.45
, pp. 756-765
-
-
Walsh, K.1
Isner, J.M.2
-
63
-
-
0033551097
-
Adenovirus-mediated delivery of fas ligand inhibits intimal hyperplasia after balloon injury in immunologically primed animals
-
Z. Luo, M. Sata, T. Nguyen, J.M. Kaplan, G.Y. Akita, and K. Walsh Adenovirus-mediated delivery of fas ligand inhibits intimal hyperplasia after balloon injury in immunologically primed animals Circulation 99 1999 1776 1779
-
(1999)
Circulation
, vol.99
, pp. 1776-1779
-
-
Luo, Z.1
Sata, M.2
Nguyen, T.3
Kaplan, J.M.4
Akita, G.Y.5
Walsh, K.6
-
64
-
-
0028205312
-
Environmental signals influencing expression of the IFN-gamma receptor on human T cells control whether IFN-gamma promotes proliferation or apoptosis
-
F. Novelli, F. Di Pierro, P. Francia di Celle, S. Bertini, P. Affaticati, and G. Garotta Environmental signals influencing expression of the IFN-gamma receptor on human T cells control whether IFN-gamma promotes proliferation or apoptosis J Immunol 152 1994 496 504
-
(1994)
J Immunol
, vol.152
, pp. 496-504
-
-
Novelli, F.1
Di Pierro, F.2
Francia Di Celle, P.3
Bertini, S.4
Affaticati, P.5
Garotta, G.6
-
66
-
-
0030985893
-
Interferon-gamma modulates a p53-independent apoptotic pathway and apoptosis-related gene expression
-
N.K. Ossina, A. Cannas, V.C. Powers, P.A. Fitzpatrick, J.D. Knight, and J.R. Gilbert Interferon-gamma modulates a p53-independent apoptotic pathway and apoptosis-related gene expression J Biol Chem 272 1997 16351 16357
-
(1997)
J Biol Chem
, vol.272
, pp. 16351-16357
-
-
Ossina, N.K.1
Cannas, A.2
Powers, V.C.3
Fitzpatrick, P.A.4
Knight, J.D.5
Gilbert, J.R.6
-
67
-
-
0036790530
-
Interferon-gamma augments CD95(APO-1/Fas) and pro-caspase-8 expression and sensitizes human vascular endothelial cells to CD95-mediated apoptosis
-
J.H. Li, M.S. Kluger, L.A. Madge, L. Zheng, A.L. Bothwell, and J.S. Pober Interferon-gamma augments CD95(APO-1/Fas) and pro-caspase-8 expression and sensitizes human vascular endothelial cells to CD95-mediated apoptosis Am J Pathol 161 2002 1485 1495
-
(2002)
Am J Pathol
, vol.161
, pp. 1485-1495
-
-
Li, J.H.1
Kluger, M.S.2
Madge, L.A.3
Zheng, L.4
Bothwell, A.L.5
Pober, J.S.6
-
68
-
-
0031738941
-
TNF-alpha and IFN-gamma render microglia sensitive to Fas ligand-induced apoptosis by induction of Fas expression and down-regulation of Bcl-2 and Bcl-xL
-
K.S. Spanaus, R. Schlapbach, and A. Fontana TNF-alpha and IFN-gamma render microglia sensitive to Fas ligand-induced apoptosis by induction of Fas expression and down-regulation of Bcl-2 and Bcl-xL Eur J Immunol 28 1998 4398 4408
-
(1998)
Eur J Immunol
, vol.28
, pp. 4398-4408
-
-
Spanaus, K.S.1
Schlapbach, R.2
Fontana, A.3
-
70
-
-
0031456015
-
Smooth muscle migration in atherosclerosis and restenosis
-
S.M. Schwartz Smooth muscle migration in atherosclerosis and restenosis J Clin Invest 100 1997 S87 S89
-
(1997)
J Clin Invest
, vol.100
-
-
Schwartz, S.M.1
-
71
-
-
0032788593
-
Interferon-beta inhibits activated leukocyte migration through human brain microvascular endothelial cell monolayer
-
J. Lou, Y. Gasche, L. Zheng, C. Giroud, P. Morel, and J. Clements Interferon-beta inhibits activated leukocyte migration through human brain microvascular endothelial cell monolayer Lab Invest 79 1999 1015 1025
-
(1999)
Lab Invest
, vol.79
, pp. 1015-1025
-
-
Lou, J.1
Gasche, Y.2
Zheng, L.3
Giroud, C.4
Morel, P.5
Clements, J.6
-
72
-
-
0037439418
-
A central role of interferon regulatory factor-1 for the limitation of neointimal hyperplasia
-
R. Wessely, L. Hengst, B. Jaschke, F. Wegener, T. Richter, and R. Lupetti A central role of interferon regulatory factor-1 for the limitation of neointimal hyperplasia Hum Mol Genet 12 2003 177 187
-
(2003)
Hum Mol Genet
, vol.12
, pp. 177-187
-
-
Wessely, R.1
Hengst, L.2
Jaschke, B.3
Wegener, F.4
Richter, T.5
Lupetti, R.6
-
73
-
-
0035912863
-
Role for p27Kip1 in vascular smooth muscle cell migration
-
J. Sun, S.O. Marx, H.-J. Chen, M. Poon, A.R. Marks, and L.E. Rabbani Role for p27Kip1 in vascular smooth muscle cell migration Circulation 103 2001 2967 2972
-
(2001)
Circulation
, vol.103
, pp. 2967-2972
-
-
Sun, J.1
Marx, S.O.2
Chen, H.-J.3
Poon, M.4
Marks, A.R.5
Rabbani, L.E.6
-
74
-
-
0026741810
-
Interferon-beta. A potential autocrine regulator of human vascular smooth muscle cell growth
-
H. Palmer, and P. Libby Interferon-beta. A potential autocrine regulator of human vascular smooth muscle cell growth Lab Invest 66 1992 715 721
-
(1992)
Lab Invest
, vol.66
, pp. 715-721
-
-
Palmer, H.1
Libby, P.2
-
75
-
-
0031647721
-
Differential effects of IFN-beta1b on the proliferation of human vascular smooth muscle and endothelial cells
-
R.J. Mintzer, E. Croze, G.M. Rubanyi, and A. Johns Differential effects of IFN-beta1b on the proliferation of human vascular smooth muscle and endothelial cells J Interferon Cytokine Res 18 1998 939 945
-
(1998)
J Interferon Cytokine Res
, vol.18
, pp. 939-945
-
-
Mintzer, R.J.1
Croze, E.2
Rubanyi, G.M.3
Johns, A.4
-
76
-
-
4143131081
-
Role of the endothelium in modulating neointimal formation: Vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions
-
N. Kipshidze, G. Dangas, M. Tsapenko, J. Moses, M.B. Leon, and M. Kutryk Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions J Am Coll Cardiol 44 2004 733 739
-
(2004)
J Am Coll Cardiol
, vol.44
, pp. 733-739
-
-
Kipshidze, N.1
Dangas, G.2
Tsapenko, M.3
Moses, J.4
Leon, M.B.5
Kutryk, M.6
-
77
-
-
0026515846
-
Regulation of xanthine dehydrogenase and xanthine oxidase activity and gene expression in cultured rat pulmonary endothelial cells
-
G.P. Dupont, T.P. Huecksteadt, B.C. Marshall, U.S. Ryan, J.R. Michael, and J.R. Hoidal Regulation of xanthine dehydrogenase and xanthine oxidase activity and gene expression in cultured rat pulmonary endothelial cells J Clin Invest 89 1992 197 202
-
(1992)
J Clin Invest
, vol.89
, pp. 197-202
-
-
Dupont, G.P.1
Huecksteadt, T.P.2
Marshall, B.C.3
Ryan, U.S.4
Michael, J.R.5
Hoidal, J.R.6
-
78
-
-
0026579534
-
Induction of tubuloreticular structures in cultured human endothelial cells by recombinant interferon alfa and beta
-
S.P. Hammar, J.Y. Luu, D.E. Bockus, F.L. Remington, J.W. Luu, and S. Friedman Induction of tubuloreticular structures in cultured human endothelial cells by recombinant interferon alfa and beta Ultrastruct Pathol 16 1992 211 218
-
(1992)
Ultrastruct Pathol
, vol.16
, pp. 211-218
-
-
Hammar, S.P.1
Luu, J.Y.2
Bockus, D.E.3
Remington, F.L.4
Luu, J.W.5
Friedman, S.6
-
79
-
-
0030725779
-
Inhibition of vascular smooth muscle cell proliferation and intimal hyperplasia by gene transfer of beta-interferon
-
D. Stephan, H. San, Z.Y. Yang, D. Gordon, S. Goelz, and G.J. Nabel Inhibition of vascular smooth muscle cell proliferation and intimal hyperplasia by gene transfer of beta-interferon Mol Med 3 1997 593 599
-
(1997)
Mol Med
, vol.3
, pp. 593-599
-
-
Stephan, D.1
San, H.2
Yang, Z.Y.3
Gordon, D.4
Goelz, S.5
Nabel, G.J.6
-
80
-
-
0028272473
-
Intimal hyperplasia, vascular modeling, and the restenosis problem
-
S. Glagov Intimal hyperplasia, vascular modeling, and the restenosis problem Circulation 89 1994 2888 2891
-
(1994)
Circulation
, vol.89
, pp. 2888-2891
-
-
Glagov, S.1
-
81
-
-
0023788435
-
Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements
-
M. Miyamoto, T. Fujita, Y. Kimura, H. Harada, Y. Sudo, and T. Miyata Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements Cell 54 1988 903 913
-
(1988)
Cell
, vol.54
, pp. 903-913
-
-
Miyamoto, M.1
Fujita, T.2
Kimura, Y.3
Harada, H.4
Sudo, Y.5
Miyata, T.6
-
82
-
-
0032943654
-
Interferon regulatory factors regulate interleukin-1beta-converting enzyme expression and apoptosis in vascular smooth muscle cells
-
M. Horiuchi, H. Yamada, M. Akishita, M. Ito, K. Tamura, and V. Dzau Interferon regulatory factors regulate interleukin-1beta-converting enzyme expression and apoptosis in vascular smooth muscle cells Hypertension 33 1999 162 166
-
(1999)
Hypertension
, vol.33
, pp. 162-166
-
-
Horiuchi, M.1
Yamada, H.2
Akishita, M.3
Ito, M.4
Tamura, K.5
Dzau, V.6
-
83
-
-
0030871033
-
Binding of the transcription factor interferon regulatory factor-1 to the inducible nitric-oxide synthase promoter
-
J. Spink, and T. Evans Binding of the transcription factor interferon regulatory factor-1 to the inducible nitric-oxide synthase promoter J Biol Chem 272 1997 24417 24425
-
(1997)
J Biol Chem
, vol.272
, pp. 24417-24425
-
-
Spink, J.1
Evans, T.2
-
84
-
-
0029148470
-
IRF-1 induced cell growth inhibition and interferon induction requires the activity of the protein kinase PKR
-
S. Kirchhoff, A.E. Koromilas, F. Schaper, M. Grashoff, N. Sonenberg, and H. Hauser IRF-1 induced cell growth inhibition and interferon induction requires the activity of the protein kinase PKR Oncogene 11 1995 439 445
-
(1995)
Oncogene
, vol.11
, pp. 439-445
-
-
Kirchhoff, S.1
Koromilas, A.E.2
Schaper, F.3
Grashoff, M.4
Sonenberg, N.5
Hauser, H.6
-
85
-
-
0029882276
-
Identification of the lysyl oxidase gene as target of the antioncogenic transcription factor, IRF-1, and its possible role in tumor suppression
-
R.S. Tan, T. Taniguchi, and H. Harada Identification of the lysyl oxidase gene as target of the antioncogenic transcription factor, IRF-1, and its possible role in tumor suppression Cancer Res 56 1996 2417 2421
-
(1996)
Cancer Res
, vol.56
, pp. 2417-2421
-
-
Tan, R.S.1
Taniguchi, T.2
Harada, H.3
-
86
-
-
0033602362
-
Activation and repression of the 2-5A synthetase and p21 gene promoters by IRF-1 and IRF-2
-
E.M. Coccia, N. Del Russo, E. Stellacci, R. Orsatti, E. Benedetti, and G. Marziali Activation and repression of the 2-5A synthetase and p21 gene promoters by IRF-1 and IRF-2 Oncogene 18 1999 2129 2137
-
(1999)
Oncogene
, vol.18
, pp. 2129-2137
-
-
Coccia, E.M.1
Del Russo, N.2
Stellacci, E.3
Orsatti, R.4
Benedetti, E.5
Marziali, G.6
-
87
-
-
2542481783
-
A comprehensive approach to visual and functional assessment of experimental vascular lesions in vivo
-
R. Wessely, M. Paschalidis, S. Wagenpfeil, F. Wegener, F.-J. Neumann, and W. Theiss A comprehensive approach to visual and functional assessment of experimental vascular lesions in vivo Am J Physiol, Heart Circ Physiol 286 2004 H2461 H2467
-
(2004)
Am J Physiol, Heart Circ Physiol
, vol.286
-
-
Wessely, R.1
Paschalidis, M.2
Wagenpfeil, S.3
Wegener, F.4
Neumann, F.-J.5
Theiss, W.6
-
88
-
-
0035851187
-
PPARgamma: A nuclear regulator of metabolism, differentiation, and cell growth
-
E.D. Rosen, and B.M. Spiegelman PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth J Biol Chem 276 2001 37731 37734
-
(2001)
J Biol Chem
, vol.276
, pp. 37731-37734
-
-
Rosen, E.D.1
Spiegelman, B.M.2
-
89
-
-
0346878909
-
Peroxisome proliferator activated receptor gamma and its activation in the treatment of insulin resistance and atherosclerosis: Issues and opportunities
-
J. Beckman, A. Raji, and J. Plutzky Peroxisome proliferator activated receptor gamma and its activation in the treatment of insulin resistance and atherosclerosis: issues and opportunities Curr Opin Cardiol 18 2003 479 485
-
(2003)
Curr Opin Cardiol
, vol.18
, pp. 479-485
-
-
Beckman, J.1
Raji, A.2
Plutzky, J.3
-
90
-
-
0033864582
-
Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice
-
A.C. Li, K.K. Brown, M.J. Silvestre, T.M. Willson, W. Palinski, and C.K. Glass Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice J Clin Invest 106 2000 523 531
-
(2000)
J Clin Invest
, vol.106
, pp. 523-531
-
-
Li, A.C.1
Brown, K.K.2
Silvestre, M.J.3
Willson, T.M.4
Palinski, W.5
Glass, C.K.6
-
91
-
-
0029861097
-
Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia
-
R.E. Law, W.P. Meehan, X.-P. Xi, K. Graf, D.A. Wuthrich, and W. Coats Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia J Clin Invest 98 1996 1897 1905
-
(1996)
J Clin Invest
, vol.98
, pp. 1897-1905
-
-
Law, R.E.1
Meehan, W.P.2
X -P. Xi3
Graf, K.4
Wuthrich, D.A.5
Coats, W.6
-
92
-
-
7444231513
-
Preventative effects of rosiglitazone on restenosis after coronary stent implantation in patients with type 2 diabetes
-
D. Choi, S.K. Kim, S.H. Choi, Y.G. Ko, C.W. Ahn, and Y. Jang Preventative effects of rosiglitazone on restenosis after coronary stent implantation in patients with type 2 diabetes Diabetes Care 27 2004 2654 2660
-
(2004)
Diabetes Care
, vol.27
, pp. 2654-2660
-
-
Choi, D.1
Kim, S.K.2
Choi, S.H.3
Ko, Y.G.4
Ahn, C.W.5
Jang, Y.6
-
93
-
-
1042279525
-
Interferon regulatory factor-1 mediates PPAR(gamma)-induced apoptosis in vascular smooth muscle cells
-
Y. Lin, X. Zhu, F.L. Mclntee, H. Xiao, J. Zhang, and M. Fu Interferon regulatory factor-1 mediates PPAR(gamma)-induced apoptosis in vascular smooth muscle cells Arterioscler Thromb Vasc Biol 24 2004 257 263
-
(2004)
Arterioscler Thromb Vasc Biol
, vol.24
, pp. 257-263
-
-
Lin, Y.1
Zhu, X.2
McLntee, F.L.3
Xiao, H.4
Zhang, J.5
Fu, M.6
-
94
-
-
0344333464
-
Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells
-
N. Marx, U. Schonbeck, M.A. Lazar, P. Libby, and J. Plutzky Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells Circ Res 83 1998 1097 1103
-
(1998)
Circ Res
, vol.83
, pp. 1097-1103
-
-
Marx, N.1
Schonbeck, U.2
Lazar, M.A.3
Libby, P.4
Plutzky, J.5
-
95
-
-
0033552883
-
Atherosclerosis-an inflammatory disease
-
R. Ross Atherosclerosis-an inflammatory disease N Engl J Med 340 1999 115 126
-
(1999)
N Engl J Med
, vol.340
, pp. 115-126
-
-
Ross, R.1
-
96
-
-
0036852824
-
Innate and acquired immunity in atherogenesis
-
C.J. Binder, M.K. Chang, P.X. Shaw, Y.I. Miller, K. Hartvigsen, and A. Dewan Innate and acquired immunity in atherogenesis Nat Med 8 2002 1218 1226
-
(2002)
Nat Med
, vol.8
, pp. 1218-1226
-
-
Binder, C.J.1
Chang, M.K.2
Shaw, P.X.3
Miller, Y.I.4
Hartvigsen, K.5
Dewan, A.6
-
98
-
-
0035062597
-
Noncytolytic control of viral infections by the innate and adaptive immune response
-
L.G. Guidotti, and F.V. Chisari Noncytolytic control of viral infections by the innate and adaptive immune response Annu Rev Immunol 19 2001 65 91
-
(2001)
Annu Rev Immunol
, vol.19
, pp. 65-91
-
-
Guidotti, L.G.1
Chisari, F.V.2
-
99
-
-
0034954034
-
Interferons alpha and beta as immune regulators-a new look
-
C.A. Biron Interferons alpha and beta as immune regulators-a new look Immunity 14 2001 661 664
-
(2001)
Immunity
, vol.14
, pp. 661-664
-
-
Biron, C.A.1
-
100
-
-
7244242357
-
Chemokines in the pathogenesis of vascular disease
-
I.F. Charo, and M.B. Taubman Chemokines in the pathogenesis of vascular disease Circ Res 95 2004 858 866
-
(2004)
Circ Res
, vol.95
, pp. 858-866
-
-
Charo, I.F.1
Taubman, M.B.2
-
101
-
-
0037196389
-
A non-classical ISRE/ISGF3 pathway mediates induction of RANTES gene transcription by type I IFNs
-
I. Cremer, J. Ghysdael, and V. Vieillard A non-classical ISRE/ISGF3 pathway mediates induction of RANTES gene transcription by type I IFNs FEBS Lett 511 2002 41 45
-
(2002)
FEBS Lett
, vol.511
, pp. 41-45
-
-
Cremer, I.1
Ghysdael, J.2
Vieillard, V.3
-
102
-
-
0035212393
-
Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1alpha by interferon-beta
-
Y.C. Zang, J.B. Halder, A.K. Samanta, J. Hong, V.M. Rivera, and J.Z. Zhang Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1alpha by interferon-beta J Neuroimmunol 112 2001 174 180
-
(2001)
J Neuroimmunol
, vol.112
, pp. 174-180
-
-
Zang, Y.C.1
Halder, J.B.2
Samanta, A.K.3
Hong, J.4
Rivera, V.M.5
Zhang, J.Z.6
-
103
-
-
0033009888
-
Natural killer cells in antiviral defense: Function and regulation by innate cytokines
-
C.A. Biron, K.B. Nguyen, G.C. Pien, L.P. Cousens, and T.P. Salazar-Mather Natural killer cells in antiviral defense: function and regulation by innate cytokines Annu Rev Immunol 17 1999 189 220
-
(1999)
Annu Rev Immunol
, vol.17
, pp. 189-220
-
-
Biron, C.A.1
Nguyen, K.B.2
Pien, G.C.3
Cousens, L.P.4
Salazar-Mather, T.P.5
-
104
-
-
0032529213
-
Type I IFNs enhance the terminal differentiation of dendritic cells
-
T. Luft, K.C. Pang, E. Thomas, P. Hertzog, D.N. Hart, and J. Trapani Type I IFNs enhance the terminal differentiation of dendritic cells J Immunol 161 1998 1947 1953
-
(1998)
J Immunol
, vol.161
, pp. 1947-1953
-
-
Luft, T.1
Pang, K.C.2
Thomas, E.3
Hertzog, P.4
Hart, D.N.5
Trapani, J.6
-
105
-
-
0029044054
-
S-100 positive cells in human arterial intima and in atherosclerotic lesions
-
Y.V. Bobryshev, and R.S. Lord S-100 positive cells in human arterial intima and in atherosclerotic lesions Cardiovasc Res 29 1995 689 696
-
(1995)
Cardiovasc Res
, vol.29
, pp. 689-696
-
-
Bobryshev, Y.V.1
Lord, R.S.2
-
106
-
-
2942516034
-
Depletion of natural killer cell function decreases atherosclerosis in low-density lipoprotein receptor null mice
-
S.C. Whitman, D.L. Rateri, S.J. Szilvassy, W. Yokoyama, and A. Daugherty Depletion of natural killer cell function decreases atherosclerosis in low-density lipoprotein receptor null mice Arterioscler Thromb Vasc Biol 24 2004 1049 1054
-
(2004)
Arterioscler Thromb Vasc Biol
, vol.24
, pp. 1049-1054
-
-
Whitman, S.C.1
Rateri, D.L.2
Szilvassy, S.J.3
Yokoyama, W.4
Daugherty, A.5
-
107
-
-
0031962665
-
Impairment of T and B cell development by treatment with a type I interferon
-
Q. Lin, C. Dong, and M.D. Cooper Impairment of T and B cell development by treatment with a type I interferon J Exp Med 187 1998 79 87
-
(1998)
J Exp Med
, vol.187
, pp. 79-87
-
-
Lin, Q.1
Dong, C.2
Cooper, M.D.3
-
108
-
-
0034814964
-
Interferon-alpha promotes survival of human primary B-lymphocytes via phosphatidylinositol 3-kinase
-
K. Ruuth, L. Carlsson, B. Hallberg, and E. Lundgren Interferon-alpha promotes survival of human primary B-lymphocytes via phosphatidylinositol 3-kinase Biochem Biophys Res Commun 284 2001 583 586
-
(2001)
Biochem Biophys Res Commun
, vol.284
, pp. 583-586
-
-
Ruuth, K.1
Carlsson, L.2
Hallberg, B.3
Lundgren, E.4
-
109
-
-
0038511317
-
IFN-gamma inhibits human airway smooth muscle cell proliferation by modulating the E2F-1/Rb pathway
-
Y. Amrani, O. Tliba, D. Choubey, C.-D. Huang, V.P. Krymskaya, and A. Eszterhas IFN-gamma inhibits human airway smooth muscle cell proliferation by modulating the E2F-1/Rb pathway Am J Physiol Lung, Cell Mol Physiol 284 2003 L1063 L1071
-
(2003)
Am J Physiol Lung, Cell Mol Physiol
, vol.284
-
-
Amrani, Y.1
Tliba, O.2
Choubey, D.3
Huang, C.-D.4
Krymskaya, V.P.5
Eszterhas, A.6
-
110
-
-
0023809126
-
Gamma-interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro
-
G.K. Hansson, L. Jonasson, J. Holm, M.M. Clowes, and A.W. Clowes Gamma-interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro Circ Res 63 1988 712 719
-
(1988)
Circ Res
, vol.63
, pp. 712-719
-
-
Hansson, G.K.1
Jonasson, L.2
Holm, J.3
Clowes, M.M.4
Clowes, A.W.5
-
111
-
-
0024510693
-
Immune interferon inhibits proliferation and induces 2′-5′- oligoadenylate synthetase gene expression in human vascular smooth muscle cells
-
S.J. Warner, G.B. Friedman, and P. Libby Immune interferon inhibits proliferation and induces 2′-5′-oligoadenylate synthetase gene expression in human vascular smooth muscle cells J Clin Invest 83 1989 1174 1182
-
(1989)
J Clin Invest
, vol.83
, pp. 1174-1182
-
-
Warner, S.J.1
Friedman, G.B.2
Libby, P.3
-
112
-
-
0026441233
-
Interferon-gamma inhibits proliferation of rat vascular smooth muscle cells by nitric oxide generation
-
Y. Nunokawa, and S. Tanaka Interferon-gamma inhibits proliferation of rat vascular smooth muscle cells by nitric oxide generation Biochem Biophys Res Commun 188 1992 409 415
-
(1992)
Biochem Biophys Res Commun
, vol.188
, pp. 409-415
-
-
Nunokawa, Y.1
Tanaka, S.2
-
113
-
-
0025800329
-
Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells
-
E.P. Amento, N. Ehsani, H. Palmer, and P. Libby Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells Arterioscler Thromb 11 1991 1223 1230
-
(1991)
Arterioscler Thromb
, vol.11
, pp. 1223-1230
-
-
Amento, E.P.1
Ehsani, N.2
Palmer, H.3
Libby, P.4
-
114
-
-
0026054932
-
Interferon-gamma inhibits arterial stenosis after injury
-
G.K. Hansson, and J. Holm Interferon-gamma inhibits arterial stenosis after injury Circulation 84 1991 1266 1272
-
(1991)
Circulation
, vol.84
, pp. 1266-1272
-
-
Hansson, G.K.1
Holm, J.2
-
115
-
-
0029162886
-
Cytokine therapy for arterial restenosis: Inhibition of neointimal hyperplasia by gamma-interferon
-
J.J. Castronuovo Jr., S.B. Guss, D. Mysh, A. Sawhney, M. Wolff, and A.M. Gown Cytokine therapy for arterial restenosis: inhibition of neointimal hyperplasia by gamma-interferon Cardiovasc Surg 3 1995 463 468
-
(1995)
Cardiovasc Surg
, vol.3
, pp. 463-468
-
-
Castronuovo Jr., J.J.1
Guss, S.B.2
Mysh, D.3
Sawhney, A.4
Wolff, M.5
Gown, A.M.6
-
116
-
-
0027476229
-
An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium
-
H. Li, M.I. Cybulsky, M.A. Gimbrone Jr., and P. Libby An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium Arterioscler Thromb 13 1993 197 204
-
(1993)
Arterioscler Thromb
, vol.13
, pp. 197-204
-
-
Li, H.1
Cybulsky, M.I.2
Gimbrone Jr., M.A.3
Libby, P.4
-
117
-
-
0028871233
-
Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines
-
H. Li, M.W. Freeman, and P. Libby Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines J Clin Invest 95 1995 122 133
-
(1995)
J Clin Invest
, vol.95
, pp. 122-133
-
-
Li, H.1
Freeman, M.W.2
Libby, P.3
-
118
-
-
0024416254
-
Detection of activated T lymphocytes in the human atherosclerotic plaque
-
G.K. Hansson, J. Holm, and L. Jonasson Detection of activated T lymphocytes in the human atherosclerotic plaque Am J Pathol 135 1989 169 175
-
(1989)
Am J Pathol
, vol.135
, pp. 169-175
-
-
Hansson, G.K.1
Holm, J.2
Jonasson, L.3
-
119
-
-
0027464928
-
Immune response in mice that lack the interferon-gamma receptor
-
S. Huang, W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, and R. Kamijo Immune response in mice that lack the interferon-gamma receptor Science 259 1993 1742 1745
-
(1993)
Science
, vol.259
, pp. 1742-1745
-
-
Huang, S.1
Hendriks, W.2
Althage, A.3
Hemmi, S.4
Bluethmann, H.5
Kamijo, R.6
-
120
-
-
0028179006
-
Lymphocyte responses and cytokines
-
W.E. Paul, and R.A. Seder Lymphocyte responses and cytokines Cell 76 1994 241 251
-
(1994)
Cell
, vol.76
, pp. 241-251
-
-
Paul, W.E.1
Seder, R.A.2
-
121
-
-
0030974188
-
IFN-gamma potentiates atherosclerosis in apoE knock-out mice
-
S. Gupta, A.M. Pablo, X.-c. Jiang, N. Wang, A.R. Tall, and C. Schindler IFN-gamma potentiates atherosclerosis in apoE knock-out mice J Clin Invest 99 1997 2752 2761
-
(1997)
J Clin Invest
, vol.99
, pp. 2752-2761
-
-
Gupta, S.1
Pablo, A.M.2
Jiang, X.C.3
Wang, N.4
Tall, A.R.5
Schindler, C.6
-
122
-
-
0034642570
-
Interferon-gamma elicits arteriosclerosis in the absence of leukocytes
-
G. Tellides, D.A. Tereb, N.C. Kirkiles-Smith, R.W. Kim, J.H. Wilson, and J.S. Schechner Interferon-gamma elicits arteriosclerosis in the absence of leukocytes Nature 403 2000 207 211
-
(2000)
Nature
, vol.403
, pp. 207-211
-
-
Tellides, G.1
Tereb, D.A.2
Kirkiles-Smith, N.C.3
Kim, R.W.4
Wilson, J.H.5
Schechner, J.S.6
-
123
-
-
0030273271
-
Platelet-derived growth factor (PDGF): Actions and mechanisms in vascular smooth muscle
-
A.D. Hughes, G.F. Clunn, J. Refson, and C. Demoliou-Mason Platelet-derived growth factor (PDGF): actions and mechanisms in vascular smooth muscle Gen Pharmacol 27 1996 1079 1089
-
(1996)
Gen Pharmacol
, vol.27
, pp. 1079-1089
-
-
Hughes, A.D.1
Clunn, G.F.2
Refson, J.3
Demoliou-Mason, C.4
-
124
-
-
0026446840
-
Mitogenic activity of interferon gamma on growth-arrested human vascular smooth muscle cells
-
T. Yokota, K. Shimokado, C. Kosaka, T. Sasaguri, J. Masuda, and J. Ogata Mitogenic activity of interferon gamma on growth-arrested human vascular smooth muscle cells Arterioscler Thromb 12 1992 1393 1401
-
(1992)
Arterioscler Thromb
, vol.12
, pp. 1393-1401
-
-
Yokota, T.1
Shimokado, K.2
Kosaka, C.3
Sasaguri, T.4
Masuda, J.5
Ogata, J.6
-
125
-
-
0030598120
-
Modulation of intercellular communication between smooth muscle cells by growth factors and cytokines
-
A. Mensink, A. Brouwer, E.H. Van den Burg, S. Geurts, W.M. Jongen, and C.M. Lakemond Modulation of intercellular communication between smooth muscle cells by growth factors and cytokines Eur J Pharmacol 310 1996 73 81
-
(1996)
Eur J Pharmacol
, vol.310
, pp. 73-81
-
-
Mensink, A.1
Brouwer, A.2
Van Den Burg, E.H.3
Geurts, S.4
Jongen, W.M.5
Lakemond, C.M.6
-
126
-
-
0030809244
-
Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts
-
H. Nagano, R.N. Mitchell, M.K. Taylor, S. Hasegawa, N.L. Tilney, and P. Libby Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts J Clin Invest 100 1997 550 557
-
(1997)
J Clin Invest
, vol.100
, pp. 550-557
-
-
Nagano, H.1
Mitchell, R.N.2
Taylor, M.K.3
Hasegawa, S.4
Tilney, N.L.5
Libby, P.6
-
127
-
-
0348201197
-
Reduced transplant arteriosclerosis in murine cardiac allografts placed in interferon-gamma knockout recipients
-
A. Raisanen-Sokolowski, T. Glysing-Jensen, J. Koglin, and M.E. Russell Reduced transplant arteriosclerosis in murine cardiac allografts placed in interferon-gamma knockout recipients Am J Pathol 152 1998 359 365
-
(1998)
Am J Pathol
, vol.152
, pp. 359-365
-
-
Raisanen-Sokolowski, A.1
Glysing-Jensen, T.2
Koglin, J.3
Russell, M.E.4
-
128
-
-
2442650602
-
Interferon-gamma plays a nonredundant role in mediating T cell-dependent outward vascular remodeling of allogeneic human coronary arteries
-
Y. Wang, W.R. Burns, P.C.Y. Tang, T. Yi, J.S. Schechner, and H.-G. Zerwes Interferon-gamma plays a nonredundant role in mediating T cell-dependent outward vascular remodeling of allogeneic human coronary arteries FASEB J 18 2004 606 608
-
(2004)
FASEB J
, vol.18
, pp. 606-608
-
-
Wang, Y.1
Burns, W.R.2
Tang, P.C.Y.3
Yi, T.4
Schechner, J.S.5
Zerwes, H.-G.6
-
129
-
-
0028085059
-
Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology
-
A.C. van der Wal, A.E. Becker, C.M. van der Loos, and P.K. Das Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology Circulation 89 1994 36 44
-
(1994)
Circulation
, vol.89
, pp. 36-44
-
-
Van Der Wal, A.C.1
Becker, A.E.2
Van Der Loos, C.M.3
Das, P.K.4
-
130
-
-
0029054734
-
Molecular bases of the acute coronary syndromes
-
P. Libby Molecular bases of the acute coronary syndromes Circulation 91 1995 2844 2850
-
(1995)
Circulation
, vol.91
, pp. 2844-2850
-
-
Libby, P.1
-
131
-
-
0037442075
-
Interferons in relapsing remitting multiple sclerosis: A systematic review
-
G. Filippini, L. Munari, B. Incorvaia, G.C. Ebers, C. Polman, and R. D'Amico Interferons in relapsing remitting multiple sclerosis: a systematic review Lancet 361 2003 545 552
-
(2003)
Lancet
, vol.361
, pp. 545-552
-
-
Filippini, G.1
Munari, L.2
Incorvaia, B.3
Ebers, G.C.4
Polman, C.5
D'Amico, R.6
-
132
-
-
0043022062
-
New and emerging treatment options for multiple sclerosis
-
C.H. Polman, and B.M.J. Uitdehaag New and emerging treatment options for multiple sclerosis Lancet Neurol 2 2003 563 566
-
(2003)
Lancet Neurol
, vol.2
, pp. 563-566
-
-
Polman, C.H.1
Uitdehaag, B.M.J.2
-
133
-
-
0041835976
-
Interferon-beta blocks infiltration of inflammatory cells and reduces infarct volume after ischemic stroke in the rat
-
W.B. Veldhuis, J.W. Derksen, S. Floris, P.H. Van Der Meide, H.E. De Vries, and J. Schepers Interferon-beta blocks infiltration of inflammatory cells and reduces infarct volume after ischemic stroke in the rat J Cereb Blood Flow Metab 23 2003 1029 1039
-
(2003)
J Cereb Blood Flow Metab
, vol.23
, pp. 1029-1039
-
-
Veldhuis, W.B.1
Derksen, J.W.2
Floris, S.3
Van Der Meide, P.H.4
De Vries, H.E.5
Schepers, J.6
-
134
-
-
0037163149
-
Innate and adaptive immunity in the pathogenesis of atherosclerosis
-
G.K. Hansson, P. Libby, U. Schonbeck, and Z.-Q. Yan Innate and adaptive immunity in the pathogenesis of atherosclerosis Circ Res 91 2002 281 291
-
(2002)
Circ Res
, vol.91
, pp. 281-291
-
-
Hansson, G.K.1
Libby, P.2
Schonbeck, U.3
Yan, Z.-Q.4
-
135
-
-
10644271869
-
Quantitative and qualitative differences in proatherogenic NKT cells in apolipoprotein E-deficient mice
-
A.S. Major, M.T. Wilson, J.L. McCaleb, Y. Ru Su, A.K. Stanic, and S. Joyce Quantitative and qualitative differences in proatherogenic NKT cells in apolipoprotein E-deficient mice Arterioscler Thromb Vasc Biol 24 2004 2351 2357
-
(2004)
Arterioscler Thromb Vasc Biol
, vol.24
, pp. 2351-2357
-
-
Major, A.S.1
Wilson, M.T.2
McCaleb, J.L.3
Ru Su, Y.4
Stanic, A.K.5
Joyce, S.6
-
136
-
-
0036556874
-
Influence of class I interferons on performance of vascular cells on stent material in vitro
-
N. Kipshidze, I. Moussa, V. Nikolaychik, V. Chekanov, A. Khanna, and A. Colombo Influence of class I interferons on performance of vascular cells on stent material in vitro Cardiovasc Radiat Med 3 2002 82 90
-
(2002)
Cardiovasc Radiat Med
, vol.3
, pp. 82-90
-
-
Kipshidze, N.1
Moussa, I.2
Nikolaychik, V.3
Chekanov, V.4
Khanna, A.5
Colombo, A.6
-
137
-
-
0028070714
-
Functional role of type I and type II interferons in antiviral defense
-
U. Muller, U. Steinhoff, L.F. Reis, S. Hemmi, J. Pavlovic, and R.M. Zinkernagel Functional role of type I and type II interferons in antiviral defense Science 264 1994 1918 1921
-
(1994)
Science
, vol.264
, pp. 1918-1921
-
-
Muller, U.1
Steinhoff, U.2
Reis, L.F.3
Hemmi, S.4
Pavlovic, J.5
Zinkernagel, R.M.6
-
138
-
-
0035571606
-
Immune mechanisms in atherosclerosis
-
G.K. Hansson Immune mechanisms in atherosclerosis Arterioscler Thromb Vasc Biol 21 2001 1876 1890
-
(2001)
Arterioscler Thromb Vasc Biol
, vol.21
, pp. 1876-1890
-
-
Hansson, G.K.1
-
139
-
-
3242876641
-
Biologic role of interferon beta in multiple sclerosis
-
A. Billiau, B.C. Kieseier, and H.-P. Hartung Biologic role of interferon beta in multiple sclerosis J Neurol 251 Suppl.2 2004 II10 II14
-
(2004)
J Neurol
, vol.251
, Issue.2 SUPPL.
-
-
Billiau, A.1
Kieseier, B.C.2
Hartung, H.-P.3
-
140
-
-
19544370237
-
The story of interferon: The ups and downs in the life of a scientist
-
E. Borden The story of interferon: the ups and downs in the life of a scientist N Engl J Med 341 1999 703 704
-
(1999)
N Engl J Med
, vol.341
, pp. 703-704
-
-
Borden, E.1
-
142
-
-
0026501563
-
Interferons and interleukin 6 suppress phosphorylation of the retinoblastoma protein in growth-sensitive hematopoietic cells
-
D. Resnitzky, N. Tiefenbrun, H. Berissi, and A. Kimchi Interferons and interleukin 6 suppress phosphorylation of the retinoblastoma protein in growth-sensitive hematopoietic cells Proc Natl Acad Sci U S A 89 1992 402 406
-
(1992)
Proc Natl Acad Sci U S a
, vol.89
, pp. 402-406
-
-
Resnitzky, D.1
Tiefenbrun, N.2
Berissi, H.3
Kimchi, A.4
-
143
-
-
0027261370
-
Interferons and interleukin-6 suppress the DNA-binding activity of E2F in growth-sensitive hematopoietic cells
-
D. Melamed, N. Tiefenbrun, A. Yarden, and A. Kimchi Interferons and interleukin-6 suppress the DNA-binding activity of E2F in growth-sensitive hematopoietic cells Mol Cell Biol 13 1993 5255 5265
-
(1993)
Mol Cell Biol
, vol.13
, pp. 5255-5265
-
-
Melamed, D.1
Tiefenbrun, N.2
Yarden, A.3
Kimchi, A.4
-
144
-
-
0032963397
-
Retardation of cell proliferation after expression of p202 accompanies an increase in p21(WAF1/CIP1)
-
J.U. Gutterman, and D. Choubey Retardation of cell proliferation after expression of p202 accompanies an increase in p21(WAF1/CIP1) Cell Growth Differ 10 1999 93 100
-
(1999)
Cell Growth Differ
, vol.10
, pp. 93-100
-
-
Gutterman, J.U.1
Choubey, D.2
-
145
-
-
11144324526
-
Alpha-interferon and its effects on signal transduction pathways
-
M. Caraglia, M. Marra, G. Pelaia, R. Maselli, M. Caputi, and S.A. Marsico Alpha-interferon and its effects on signal transduction pathways J Cell Physiol 202 2005 323 335
-
(2005)
J Cell Physiol
, vol.202
, pp. 323-335
-
-
Caraglia, M.1
Marra, M.2
Pelaia, G.3
Maselli, R.4
Caputi, M.5
Marsico, S.A.6
-
146
-
-
0035958901
-
The p38 MAPK pathway mediates the growth inhibitory effects of interferon-alpha in BCR-ABL-expressing cells
-
I.A. Mayer, A. Verma, I.M. Grumbach, S. Uddin, F. Lekmine, and F. Ravandi The p38 MAPK pathway mediates the growth inhibitory effects of interferon-alpha in BCR-ABL-expressing cells J Biol Chem 276 2001 28570 28577
-
(2001)
J Biol Chem
, vol.276
, pp. 28570-28577
-
-
Mayer, I.A.1
Verma, A.2
Grumbach, I.M.3
Uddin, S.4
Lekmine, F.5
Ravandi, F.6
|